These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 15686221)

  • 1. [Adverse events following BCG vaccination].
    Sagić L
    Med Pregl; 2004; 57 Suppl 1():41-7. PubMed ID: 15686221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphadenitis as a complication following vaccination with Bacillus Calmette-Guérin (BCG)].
    Cerdá de Palou E; de Santy HP
    Ned Tijdschr Geneeskd; 2003 Mar; 147(12):569-72. PubMed ID: 12693089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
    Szczuka I
    Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HIV-infection, AIDS and BCG vaccination].
    Toida I
    Kekkaku; 1993 Jun; 68(6):435-44. PubMed ID: 8341039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of intradermal Bacillus Calmette-Guerin vaccine for neonates in Eastern Saudi Arabia.
    Al-Salem AH; Kothari MR; AlHani HM; Oquaish MM; Khogeer SS; Desouky MS
    Saudi Med J; 2012 Feb; 33(2):172-6. PubMed ID: 22327758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.
    Nissen TN; Birk NM; Kjærgaard J; Thøstesen LM; Pihl GT; Hoffmann T; Jeppesen DL; Kofoed PE; Greisen G; Benn CS; Aaby P; Pryds O; Stensballe LG
    Vaccine; 2016 May; 34(22):2477-82. PubMed ID: 27060379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus Calmette-Guerin (BCG) lymphadenitis-changing trends and management.
    Nazir Z; Qazi SH
    J Ayub Med Coll Abbottabad; 2005; 17(4):16-8. PubMed ID: 16599027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Needle aspiration as a diagnostic tool and therapeutic modality in suppurative lymphadenitis following Bacillus Calmette Guerin vaccination.
    Sataynarayana S; Mathur AD; Verma Y; Pradhan S; Bhandari MK
    J Assoc Physicians India; 2002 Jun; 50():788-91. PubMed ID: 12240843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe axillary lymphadenitis after BCG vaccination: alert for primary immunodeficiencies.
    Santos A; Dias A; Cordeiro A; Cordinhã C; Lemos S; Rocha G; Faria E
    J Microbiol Immunol Infect; 2010 Dec; 43(6):530-7. PubMed ID: 21195982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
    De Britto RL; Ramanathan VD; Gupte MD
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacille Calmette-Guérin lymphadenitis.
    Goraya JS; Virdi VS
    Postgrad Med J; 2002 Jun; 78(920):327-9. PubMed ID: 12151684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity status in children with Bacille Calmette-Guerin adenitis. A prospective study in Tehran, Iran.
    Samileh N; Ahmad S; Farzaneh A; Shahnaz R; Lida F; Mohammad N
    Saudi Med J; 2006 Nov; 27(11):1719-24. PubMed ID: 17106549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular confirmation of Bacillus Calmette Guerin vaccine related adverse events among Saudi Arabian children.
    Al-Hajoj S; Memish Z; Abuljadayel N; AlHakeem R; AlRabiah F; Varghese B
    PLoS One; 2014; 9(11):e113472. PubMed ID: 25409184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regional suppurative lymphadenitis after BCG vaccination (author's transl)].
    Brehmer W; Falkenberg N; Hussels H; Otto HS; Preussler H; Waldschmidt J
    Dtsch Med Wochenschr; 1977 Sep; 102(35):1251-5. PubMed ID: 902587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adverse event after BCG vaccination in Poland in the years 1994-1997].
    Szczuka I
    Pneumonol Alergol Pol; 1999; 67(5-6):208-16. PubMed ID: 10570642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adverse events following BCG vaccination in infants and children up to 36 months of age].
    Gołebiowska M; Andrzejewska E; Stryjewska I; Baranowska H; Drazkiewicz A
    Przegl Epidemiol; 2008; 62(1):71-5. PubMed ID: 18536227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rate of adverse events following BCG vaccination in Poland.
    Krysztopa-Grzybowska K; Paradowska-Stankiewicz I; Lutyńska A
    Przegl Epidemiol; 2012; 66(3):465-9. PubMed ID: 23230718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [BCG vaccination: characteristics of drugs and causes of vaccinal complications].
    Levi DT; Aksenova VA; Zakirova NR; Aleksandrova NV
    Probl Tuberk; 1999; (4):4-7. PubMed ID: 10479921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe adverse reactions after vaccination with Japanese BCG vaccine: a review].
    Toida I; Nakata S
    Kekkaku; 2007 Nov; 82(11):809-24. PubMed ID: 18078106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent problem of skin lesions induced by BCG vaccination].
    Mori T; Yamauchi Y
    Kekkaku; 2009 Mar; 84(3):109-15. PubMed ID: 19364042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.